Breaking News Bar

Business News and Information

Recent Quotes
My Watchlist
Indicators
Local Stocks
The Daily Herald Market Index
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

(NQ: )

N/A UNCHANGED
Last Price Updated: Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All news about

< Previous 1 2 3 4 5 6 7 8 9
...
75 76 Next >
Interesting ARNA Put And Call Options For August 17th
Investors in Arena Pharmaceuticals Inc (ARNA) saw new options begin trading this week, for the August 17th expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the ARNA... 
Tags Stocks
From Market News Video
First Week of September 21st Options Trading For Arena Pharmaceuticals (ARNA)
Investors in Arena Pharmaceuticals Inc (ARNA) saw new options begin trading this week, for the September 21st expiration. One of the key data points that goes into the price an option buyer is willing... 
Tags Stocks
From Market News Video
Five outperforming health-care funds and the top 10 stocks they hold
The group of mutual funds is highly rated for outperforming the S&P 500 health-care sector. 
Tags ANTM Biotechnology CH:ROG
From MarketWatch
Biotech Stocks Emerge Unscathed And Ready To Go
The biotech stocks have been demonstrating strong resilience in the face of intense volatility since February and, remarkably, keeping pace with the broader indexes, considering the highly speculative... 
Tags Healthcare Stocks / Equities Pharma/Biotech
From Blogs - TalkMarkets
Arena Pharmaceuticals Provides Corporate Update and Reports First Quarter 2018 Financial Results
- Achieved positive Phase 2 results for etrasimod in ulcerative colitis in March; Phase 3 preparations for ulcerative colitis and a development plan for Crohn's disease underway 
From PR Newswire
ARNA June 8th Options Begin Trading
Investors in Arena Pharmaceuticals Inc (ARNA) saw new options become available today, for the June 8th expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the ARNA... 
Tags Stocks
From Market News Video
Analysts Expect 54% Gains Ahead For The Holdings of XBI
Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and... 
Tags ETFs
From ETF Channel
ARNA May 11th Options Begin Trading
Investors in Arena Pharmaceuticals Inc (ARNA) saw new options begin trading today, for the May 11th expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the ARNA options... 
Tags Stocks
From Market News Video
Arena Pharmaceuticals Announces Completion of Public Offering of Common Stock and Exercise in Full of Underwriters' Option to Purchase Additional Shares
Arena Pharmaceuticals, Inc. (Nasdaq: ARNA) today announced the completion of its previously announced underwritten public offering of 9,775,000 shares of its common stock at a price to the public of... 
From PR Newswire
This Obesity Drugmaker Just Made a Comeback While Another Declared Bankruptcy
Tags CELG ARNA OREX
From Motley Fool
PetroYuan vs. PetroDollar… Dollar Crisis?
The PetroYuan is the new competitor to the US PetroDollar. This is the first competition to the PertroDollar since the early 1970’s when President Nixon took the United States off of the Gold... 
Tags Currencies/Forex Basic Materials / Commodities Stocks / Equities
From Blogs - TalkMarkets
Arena Pharmaceuticals to Present at the 17th Annual Needham Healthcare Conference on March 27
Arena Pharmaceuticals, Inc. (NASDAQ: ARNA) today announced that Amit D. Munshi, the Company's President and Chief Executive Officer, will present a corporate update at the 17th Annual Needham... 
From PR Newswire
Arena Pharmaceuticals Takes Aim at Celgene
Tags ARNA CELG
From Motley Fool
Investors Pick Up ARNA Even Cheaper Than Its Secondary Stock Offering
Looking back to 2 days ago, Arena Pharmaceuticals Inc (ARNA) priced a 8,500,000 share secondary stock offering at $41.50 per share. Buyers in that offering made a considerable investment into the... 
Tags Stocks
From Market News Video
One Biotech Turnaround to Watch
Tags ARNA
From Motley Fool
Why Whiting Petroleum, Arena Pharmaceuticals, and First Majestic Silver Jumped Today
Tags WLL AG ARNA
From Motley Fool
Here's Why Arena Pharmaceuticals, Inc. Surged Again on Wednesday
Tags ARNA
From Motley Fool
Morning Call For Wednesday, March 21
Jun E-mini S&Ps (ESM18 -0.01%) this morning are down -0.01% and European stocks are down -0.04% as the markets await the FOMC's first policy decision with Jerome Powell as Fed Chair. 
Tags Commodities Bonds Currencies/Forex
From Blogs - TalkMarkets
Rising crude oil prices lift markets to higher close
The markets recovered to close higher with the Dow soaring 116 points to 24,727 as crude oil prices climbed. Nasdaq gained 20 points to 7364. 
Tags Market News
From MarketMinute.com Market Updates
After-hours buzz: FDX, MULE, CRM & more
See which stocks are posting big moves after the bell. 
Tags Market Insider Economics/Economy Business/Earnings
From CNBC.com News
Arena Pharmaceuticals reports positive study results
Arena Pharmaceuticals Inc. (Nasdaq: ARNA) reported positive results from a Phase 2 OASIS trial for etrasimod to treat ulcerative colitis. Shares of the biopharmaceutical leaped $8.86 to close at... 
From MarketMinute.com Stock News
What Happened in the Stock Market Today
Tags CELG XLE ARNA
From Motley Fool
Arena Pharmaceuticals Announces Proposed Public Offering of Common Stock
Arena Pharmaceuticals, Inc. (Nasdaq: ARNA) today announced that it intends to offer and sell, subject to market and other conditions, 7,500,000 shares of its common stock in an underwritten public... 
From PR Newswire
Mid-Afternoon Market Update: MuleSoft Gains Following Report Of Takeover Interest From Salesforce; Proteostasis Therapeutics Shares Slide
Toward the end of trading Tuesday, the Dow traded up 0.45 percent to 24,722.29 while the NASDAQ gained 0.15 percent to 7,355.20. The ... 
Tags PTI MULE CRM
From Benzinga
28 Stocks Moving In Tuesday's Mid-Day Session
Gainers Arena Pharmaceuticals, Inc. (NASDAQ: ARNA) shares climbed 31.8 percent to $40.7376 as the company reported topline ... 
Tags HQY DLTH Movers
From Benzinga
Why Arena Pharmaceuticals Shares Are Rocketing 31.6% Higher Today
Tags ARNA CELG
From Motley Fool
Arena Pharmaceuticals Jumps After Ulcerative Colitis Trial Hits Targets
Shares of Arena Pharmaceuticals are on the rise after the company said its ulcerative colitis drug met its primary, secondary, and clinical remission endpoints in a Phase 2 trial. 
Tags Stocks / Equities Healthcare
From Blogs - TalkMarkets
Mid-Day Market Update: Crude Oil Up 2.5%; Arena Pharmaceuticals Shares Spike Higher
Midway through trading Tuesday, the Dow traded up 0.62 percent to 24,762.41 while the NASDAQ gained 0.37 percent to 7,371.19. The ... 
Tags Benzinga ORCL Mid/Day Market Update
From Benzinga
Biotech Stock Jumps By A Third As Rivalry With Celgene Heats
Arena gapped up by nearly a third Tuesday after its ulcerative colitis drug proved strong in a Phase 2 trial. 
From Investor's Business Daily
Mid-Morning Market Update: Markets Gain; Oracle Shares Fall Following Q3 Results
Following the market opening Tuesday, the Dow traded up 0.53 percent to 24,740.03 while the NASDAQ gained 0.19 percent to 7,358.48. The ... 
Tags ORCL Benzinga Mid/Morning Market Update
From Benzinga
< Previous 1 2 3 4 5 6 7 8 9
...
75 76 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
 
bottom clear
Search DailyHerald.com for articles
More ways to search Daily Herald
Obituaries
Search DailyHerald.com obituaries. » Daily Herald newspaper archive
Find archived newspaper articles back to 1901. »
Digital Subscriptions
Activate Subscriber Access Purchase a Digital Subscription
Home Delivery
Start a New Subscription Manage Account